aim
vaccin
everi
anim
core
vaccin
vaccin
individu
less
frequent
give
vaccin
necessari
anim
wsava
vaccin
guidelin
group
vgg
conven
respons
produc
global
vaccin
guidelin
dog
cat
would
consid
intern
differ
econom
societ
factor
impact
keep
small
companion
anim
launch
wsava
congress
contemporan
publish
journal
small
anim
practic
day
et
al
english
spanish
version
made
publicli
avail
wsava
websit
recognit
rapidli
develop
field
companion
anim
medicin
vgg
reconven
target
updat
guidelin
veterinarian
prepar
new
set
guidelin
direct
owner
breeder
dog
cat
vgg
met
three
occas
activ
electron
commun
meet
present
document
repres
conclus
first
target
vgg
well
progress
toward
launch
guidelin
first
activ
second
phase
vgg
assess
impact
guidelin
intern
veterinari
commun
achiev
goal
develop
simpl
questionnair
circul
wsava
member
countri
wsava
assembl
repres
follow
question
ask
guidelin
wide
avail
veterinarian
countri
guidelin
discuss
nation
small
anim
veterinari
associ
nation
small
anim
veterinari
associ
guidelin
vaccin
dog
cat
nation
small
anim
veterinari
associ
adopt
wsava
guidelin
signific
conflict
wsava
guidelin
nation
practic
companion
anim
medic
care
countri
vaccin
guidelin
also
ask
send
copi
vgg
respons
receiv
countri
develop
develop
nation
guidelin
gener
access
veterinari
commun
respond
case
reason
often
unavail
translat
version
notabl
lack
comput
internet
access
gener
practic
also
flag
develop
nation
guidelin
discuss
small
anim
veterinari
associ
respond
countri
thirteen
respond
countri
alreadi
nation
guidelin
place
case
smaller
european
countri
adopt
use
larger
neighbour
vgg
privileg
abl
assess
six
nation
guidelin
document
rang
excel
succinct
summari
detail
substanti
paper
provid
solid
background
discuss
immunolog
vaccin
vgg
pleas
note
countri
without
vaccin
guidelin
nation
organ
either
fulli
adopt
recommend
wsava
guidelin
current
use
develop
nation
recommend
also
clear
countri
public
guidelin
precipit
discuss
nation
organ
sometim
driven
pressur
gener
public
respond
indic
rang
minor
conflict
wsava
guidelin
nation
practic
great
anticip
exampl
mani
countri
maintain
legal
annual
revaccin
rabi
countri
access
full
rang
product
list
guidelin
eg
individu
compon
product
extend
doi
product
other
specif
nation
product
local
manufactur
global
avail
respons
questionnair
underlin
import
global
vaccin
guidelin
current
revis
aim
document
updat
extend
inform
given
version
much
text
recommend
remain
specif
chang
clear
indic
purpos
guidelin
discuss
passiv
immun
particular
canin
distemp
viru
cdv
assess
vaccin
canin
influenza
viru
civ
leishmaniosi
malign
differ
approach
felin
upper
respiratori
viru
fcv
felin
leukaemia
viru
felv
site
vaccin
updat
canin
parvoviru
cpv
new
fact
sheet
rabi
expand
list
frequent
ask
question
faq
feedback
suggest
aspect
guidelin
document
particularli
use
imag
bank
major
canin
felin
diseas
vgg
believ
imag
great
valu
practic
veterinarian
vaccin
interview
client
imag
freeli
avail
via
wsava
websit
provid
visual
evid
signific
sever
infecti
diseas
may
prevent
vaccin
imag
may
use
consult
room
whilst
address
vaccin
pet
owner
vgg
acknowledg
import
work
undertaken
american
anim
hospit
associ
aaha
canin
vaccin
task
forc
paul
et
al
american
associ
felin
practition
aafp
felin
vaccin
advisori
panel
richard
et
al
address
companion
anim
vaccin
issu
sinc
public
wsava
guidelin
european
advisori
board
cat
diseas
abcd
also
formul
recommend
felin
vaccin
european
perspect
work
group
recent
cumul
public
special
issu
journal
felin
medicin
surgeri
horzinek
thiri
speak
practition
audienc
guidelin
clear
widespread
confus
purpos
mani
practition
initi
alarm
recommend
appear
contrari
given
product
data
sheet
therefor
feel
adopt
guidelin
recommend
leav
open
litig
distinct
differ
data
sheet
guidelin
document
clearli
discuss
recent
paper
thiri
horzinek
data
sheet
summari
product
characterist
spc
legal
document
form
part
registr
process
vaccin
data
sheet
give
detail
qualiti
safeti
efficaci
product
case
vaccin
describ
legal
doi
product
legal
doi
base
experiment
evid
repres
minimum
valu
need
reflect
true
doi
vaccin
companion
anim
vaccin
recent
year
doi
carri
recommend
annual
revaccin
sensibl
respons
industri
recent
discuss
vaccin
safeti
increasingli
licens
product
extend
gener
year
doi
howev
core
vaccin
see
true
doi
like
consider
longer
instanc
guidelin
may
recommend
triennial
vaccin
product
still
carri
year
licens
doi
simpl
reason
guidelin
base
current
scientif
knowledg
think
wherea
data
sheet
reflect
knowledg
avail
time
vaccin
receiv
origin
licens
may
year
earlier
consequ
guidelin
advic
often
differ
given
data
sheet
howev
veterinarian
may
use
vaccin
accord
guidelin
therefor
current
scientif
think
obtain
inform
document
owner
consent
deviat
legal
recommend
use
confus
often
caus
compani
repres
advis
legal
oblig
veterinarian
must
adher
data
sheet
recommend
point
confus
aris
veterinarian
compar
recommend
given
differ
set
guidelin
exampl
subtl
differ
recommend
made
usa
europ
reflect
differ
opinion
local
expert
group
percept
lifestyl
pet
anim
may
make
less
expos
infect
vgg
face
difficult
challeng
set
variou
nation
region
guidelin
recommend
attempt
provid
balanc
perspect
account
global
differ
keep
small
companion
anim
summari
veterinarian
feel
comfort
vaccin
accord
schedul
given
guidelin
local
recommend
avail
vgg
recommend
differ
current
legal
requir
practition
need
obtain
inform
client
consent
provid
client
anim
current
vaccin
schedul
aim
vaccin
everi
anim
core
vaccin
vaccin
individu
less
frequent
give
vaccin
necessari
anim
guidelin
recommend
core
recommend
option
recommend
vaccin
gener
veterinari
practic
given
tabl
vgg
consid
core
vaccin
one
puppi
throughout
world
must
receiv
order
provid
protect
infecti
diseas
global
signific
vgg
recogn
particular
countri
identifi
addit
vaccin
consid
core
particular
exampl
vaccin
may
consid
core
countri
rabi
viru
geograph
area
infect
endem
dog
routin
vaccin
protect
pet
human
popul
countri
mandatori
rabi
vaccin
legal
requir
gener
also
requir
intern
pet
travel
vaccin
licens
dog
whose
use
determin
basi
anim
geograph
lifestyl
exposur
assess
ratio
recommend
vaccin
littl
scientif
justif
use
pup
protect
mda
first
week
life
gener
passiv
immun
wane
week
age
level
allow
activ
immun
pup
poor
mda
may
vulner
capabl
respond
vaccin
earlier
age
other
may
possess
mda
high
titr
incap
respond
vaccin
week
age
singl
primari
vaccin
polici
therefor
cover
possibl
situat
recommend
vgg
initi
vaccin
week
age
follow
second
vaccin
week
later
third
vaccin
given
week
age
contrast
present
mani
vaccin
data
sheet
recommend
initi
cours
two
inject
product
also
licens
week
finish
design
second
two
vaccin
given
week
age
rational
behind
protocol
permit
earli
social
pup
vgg
recogn
great
benefit
behaviour
develop
dog
protocol
adopt
great
caution
still
maintain
owner
allow
restrict
exposur
pup
control
area
pup
healthi
fulli
vaccin
vgg
recommend
whenev
possibl
third
dose
core
vaccin
given
week
age
immunolog
term
repeat
inject
given
pup
first
year
life
constitut
booster
rather
attempt
induc
primari
immun
respons
inject
attenu
viru
modifi
live
viru
mlv
vaccin
anim
devoid
neutral
antibodi
must
multipli
process
antigen
present
cell
stimul
b
lymphocyt
case
kill
inactiv
vaccin
mda
may
also
interfer
immunolog
process
bind
mask
relev
antigen
repeat
dose
requir
dog
receiv
first
booster
month
complet
primari
vaccin
cours
vgg
redefin
basic
immun
protocol
ensembl
pup
regim
plu
first
booster
month
booster
also
ensur
immun
dog
may
adequ
respond
pup
vaccin
dog
respond
vaccin
mlv
core
vaccin
maintain
solid
immun
immunolog
memori
mani
year
absenc
repeat
vaccin
follow
month
booster
subsequ
revaccin
given
interv
year
longer
unless
special
condit
appli
emphas
consider
given
gener
appli
kill
core
vaccin
option
vaccin
particularli
vaccin
contain
bacteri
antigen
thu
leptospira
bordetella
borrelia
lyme
diseas
product
also
parainfluenza
viru
compon
requir
frequent
booster
reliabl
protect
therefor
adult
dog
may
today
still
revaccin
annual
compon
vaccin
may
differ
year
typic
core
vaccin
current
administ
triennial
chosen
product
given
annual
vgg
awar
countri
product
contain
core
combin
avail
vgg
would
encourag
manufactur
make
full
rang
vaccin
avail
wherev
possibl
adult
dog
receiv
complet
cours
core
vaccin
puppi
follow
month
booster
may
regularli
vaccin
adult
requir
singl
dose
core
vaccin
boost
immun
mani
current
data
sheet
advis
circumst
dog
requir
two
vaccin
puppi
practic
unjustifi
simpli
contrari
fundament
principl
immunolog
memori
contrast
approach
may
justifi
adult
dog
unknown
vaccin
histori
serolog
test
perform
antibodi
test
use
monitor
immun
cdv
rabi
viru
antibodi
assay
cdv
test
greatest
benefit
monitor
immun
especi
puppi
vaccin
seri
recent
year
mani
laboratori
standard
methodolog
test
legal
requir
rabi
antibodi
test
pet
travel
countri
test
probabl
becom
popular
soon
rapid
simpl
reliabl
assay
wide
avail
neg
test
result
indic
anim
littl
antibodi
revaccin
recommend
dog
fact
immun
revaccin
would
unnecessari
posit
test
result
hand
would
lead
conclus
revaccin
requir
robust
yesno
answer
must
provid
assay
cdv
andor
test
anim
neg
result
regardless
test
use
consid
antibodi
suscept
infect
complet
puppi
seri
week
age
anim
posit
test
result
provid
serum
sampl
collect
week
vaccin
seroneg
anim
revaccin
retest
test
neg
consid
possibl
incap
develop
protect
immun
test
antibodi
present
practic
way
ensur
puppi
immun
system
recogn
vaccin
antigen
vaccin
may
fail
variou
reason
common
reason
vaccin
failur
howev
last
vaccin
dose
given
week
age
mda
decreas
low
level
activ
immun
succeed
puppi
poor
immunogen
may
reflect
rang
factor
stage
vaccin
manufactur
administr
anim
exampl
viru
strain
passag
histori
product
error
manufactur
particular
batch
product
may
caus
vaccin
failur
factor
incorrect
storag
transport
interrupt
cold
chain
handl
disinfect
use
vaccin
veterinari
practic
may
result
inactiv
mlv
product
anim
fail
develop
antibodi
respons
repeat
revaccin
consid
immunolog
genet
control
speci
certain
breed
dog
suspect
believ
unproven
high
suscept
recogn
certain
rottweil
doberman
regardless
vaccin
histori
due
high
preval
usa
today
two
breed
seem
greater
number
breed
possibl
carrier
genet
trait
may
die
infect
dog
breed
may
low
antigen
exampl
uk
germani
phenotyp
preval
amongst
rottweil
rabi
viru
recent
studi
shown
breed
higher
proport
anim
fail
achiev
titr
rabi
antibodi
requir
pet
travel
vaccin
dog
persist
serum
antibodi
core
vaccin
antigen
mani
year
immunolog
antibodi
reflect
function
distinct
popul
plasma
cell
memori
effector
b
cell
induct
immunolog
memori
primari
object
vaccin
core
vaccin
excel
correl
presenc
antibodi
protect
immun
long
doi
product
correl
exist
mani
vaccin
doi
relat
product
necessit
frequent
revaccin
interv
antibodi
test
use
demonstr
doi
vaccin
core
vaccin
known
dog
often
maintain
protect
antibodi
cdv
three
year
numer
experiment
studi
support
observ
therefor
antibodi
absent
irrespect
serolog
test
use
dog
revaccin
unless
medic
basi
antibodi
determin
vaccin
compon
limit
valu
short
time
period
antibodi
persist
eg
leptospira
product
lack
correl
serum
antibodi
protect
eg
leptospira
canin
parainfluenza
import
consider
perform
antibodi
test
cost
time
obtain
result
vgg
recogn
present
serolog
test
limit
avail
might
rel
expens
howev
principl
veterinari
medicin
would
dictat
test
antibodi
statu
either
pup
adult
dog
better
practic
simpli
administ
vaccin
booster
basi
safe
cost
less
respons
need
rapid
test
develop
vaccin
ie
activ
immun
domin
infecti
diseas
prevent
passiv
immun
also
vener
histori
first
serum
hyperimmun
sera
avail
protect
human
infant
anthrax
botul
scarlet
fever
adult
respiratori
syncyti
viru
hepat
b
mump
measl
rabi
although
viru
infect
trigger
cellular
humor
immun
mainli
antibodi
respons
contribut
reduct
viral
load
recoveri
mani
viru
infect
antibodi
level
therefor
taken
correl
protect
viraemia
inject
antibodi
direct
surfac
structur
virion
latch
particl
neutral
infect
prepar
remov
therapeut
serum
immunoglobulin
prepar
inject
subcutan
quickli
reach
circul
unexpectedli
intraven
infus
plasma
serum
found
work
well
difficult
practic
must
use
caution
local
infect
initi
bite
wound
rabid
carnivor
antibodi
prophylaxi
also
proven
invalu
human
rabi
immun
globulin
provid
rapid
protect
given
first
day
prophylaxi
regimen
much
possibl
prepar
infiltr
around
wound
may
given
intramuscularli
site
distant
rabi
vaccin
appli
simultan
companion
anim
practic
prevent
activ
immun
commonplac
serum
prophylaxistherapi
consid
except
circumst
eg
dog
present
distemp
cat
present
panleukopenia
diseas
outbreak
kennelcatteri
still
market
serum
immunoglobulin
product
compani
produc
exist
usa
germani
czech
republ
slovakia
russia
brazil
prepar
either
homolog
heterolog
hors
origin
polyval
direct
sever
virus
consist
sera
immunoglobulin
fraction
despit
avail
product
vgg
recommend
use
conserv
care
consider
case
outbreak
cdv
infect
kennel
much
safer
effect
vaccin
dog
cdv
vaccin
rather
give
immun
serum
situat
previous
recommend
mlv
vaccin
administ
intraven
rather
subcutan
intramuscularli
littl
evid
practic
provid
effect
protect
subcutan
inject
administr
cdv
vaccin
rout
provid
protect
sever
diseas
death
immedi
vaccin
instanc
vaccin
prevent
infect
instead
protect
diseas
especi
neurolog
diseas
anim
surviv
subsequ
immun
life
case
catteri
outbreak
fpv
infect
kennel
outbreak
infect
recent
experi
shown
immun
serum
given
clinic
sign
appear
benefit
reduct
morbid
mortal
order
benefici
effect
immun
serum
must
given
infect
prior
onset
clinic
sign
case
administr
immun
serum
must
within
hour
infect
larg
amount
high
titr
serum
requir
serum
must
given
parenter
eg
subcutan
intraperiton
oral
benefit
oral
administr
even
treatment
start
prior
infect
import
consider
shelter
situat
rel
cost
commerci
product
altern
practic
sometim
use
shelter
situat
collect
serum
anim
shelter
surviv
diseas
recent
vaccin
howev
practic
carri
risk
serum
necessarili
screen
transmiss
pathogen
eg
haemoparasit
felin
retrovirus
effect
approach
control
diseas
outbreak
shelter
situat
would
use
serolog
test
determin
serum
antibodi
titr
identifi
anim
protect
therefor
safe
left
shelter
face
diseas
outbreak
anim
suscept
therefor
like
becom
infect
possibl
die
therefor
euthan
suscept
popul
euthan
anim
isol
adopt
foster
certain
infect
new
canin
vaccin
becom
avail
countri
although
scientif
literatur
assess
product
applic
limit
vgg
given
preliminari
consider
emphas
may
fulli
licens
product
limit
region
avail
new
vaccin
canin
influenza
viru
civ
infect
receiv
condit
licens
usa
june
influenza
subtyp
particular
problem
north
america
anim
hous
togeth
date
sporad
case
recogn
elsewher
europ
civ
vaccin
contain
inactiv
viru
administ
pup
week
age
booster
week
later
annual
revaccin
immun
develop
approxim
day
second
dose
vaccin
consid
recommend
dog
like
encount
group
exposur
part
lifestyl
first
canin
immunotherapeut
vaccin
malign
melanoma
receiv
condit
licens
usa
march
fulli
licens
product
compris
human
tyrosinas
gene
incorpor
plasmid
nake
dna
vaccin
repeatedli
deliv
use
transderm
inject
devic
vaccin
use
dog
receiv
tradit
treatment
oral
melanoma
induc
immun
respons
melanoma
target
antigen
studi
show
median
surviv
time
dog
grade
melanoma
increas
day
expect
surviv
day
bergman
et
al
vaccin
also
recent
becom
avail
europ
usa
limit
use
recogn
veterinari
oncolog
specialist
increas
bodi
scientif
literatur
evalu
first
licens
vaccin
canin
leishmaniosi
product
licens
brazil
leishmaniosi
diseas
major
import
canin
human
popul
activ
programm
cull
seroposit
infect
dog
reduc
reservoir
popul
vaccin
subunit
product
contain
l
donovani
also
known
fucos
mannos
ligand
saponin
adjuv
consid
induc
antibodi
block
transmiss
organ
dog
sand
fli
vector
prevent
bind
leishmania
midgut
sand
fli
vaccin
appear
compat
serolog
test
identifi
infect
dog
vaccin
uninfect
anim
posit
test
use
screen
programm
importantli
larg
scale
epidemiolog
studi
shown
vaccin
addit
effect
cull
programm
region
high
uptak
vaccin
show
reduc
incid
canin
human
infect
palatnik
de
sousa
et
al
find
add
support
concept
vaccin
might
consid
core
countri
brazil
guidelin
recommend
core
recommend
option
recommend
vaccin
gener
veterinari
practic
given
tabl
particular
exampl
vaccin
may
consid
core
countri
rabi
viru
geograph
area
infect
endem
cat
routin
vaccin
protect
pet
human
popul
countri
mandatori
rabi
vaccin
legal
requir
gener
also
requir
intern
pet
travel
term
felin
core
vaccin
import
realiz
protect
afford
fcv
vaccin
provid
efficaci
immun
seen
fpv
vaccin
thu
felin
core
vaccin
expect
give
robust
protect
durat
immun
seen
canin
core
vaccin
although
fcv
vaccin
design
produc
immun
sever
clinic
diseas
multipl
strain
fcv
possibl
infect
mild
diseas
occur
vaccin
anim
respect
rememb
herpesviru
vaccin
protect
infect
virul
viru
virul
viru
becom
latent
may
reactiv
period
sever
stress
reactiv
viru
may
caus
clinic
sign
vaccin
anim
viru
shed
suscept
anim
caus
diseas
vgg
adopt
recommend
triennial
revaccin
fcv
appreci
point
debat
amongst
expert
exampl
abdc
recommend
annual
revaccin
cat
consid
high
risk
triennial
revaccin
low
risk
predominantli
indoor
anim
vaccin
felin
leukaemia
viru
felv
also
often
point
debat
amongst
expert
vgg
regard
felv
vaccin
tabl
fulli
appreci
use
product
may
determin
lifestyl
perceiv
exposur
risk
individu
cat
preval
infect
local
environ
mani
felin
expert
believ
even
though
preval
felv
infect
markedli
reduc
due
success
vaccin
control
programm
cat
less
year
old
element
outdoor
lifestyl
receiv
benefit
protect
routin
vaccin
dose
vaccin
given
week
apart
start
earlier
week
age
analysi
felv
form
routin
part
felin
vaccin
interview
discuss
pup
kitten
protect
mda
first
week
life
howev
without
serolog
test
level
protect
point
kitten
becom
suscept
infect
andor
respond
immunolog
vaccin
unknown
relat
level
matern
antibodi
variat
uptak
mda
litter
gener
mda
wane
week
age
level
allow
activ
immunolog
respons
initi
vaccin
week
age
follow
second
vaccin
week
later
commonli
recommend
mani
vaccin
carri
data
sheet
recommend
effect
howev
kitten
poor
mda
may
vulner
capabl
respond
vaccin
earlier
age
other
may
possess
mda
high
titr
incap
respond
vaccin
sometim
week
age
therefor
vgg
recommend
administr
final
kitten
dose
week
older
kitten
receiv
core
vaccin
minimum
three
dose
one
week
age
second
week
later
final
dose
week
age
older
administ
cat
respond
mlv
core
vaccin
maintain
immun
mani
year
absenc
repeat
vaccin
cat
receiv
first
booster
within
month
complet
kitten
vaccin
cours
ensur
adequ
immun
cat
may
adequ
respond
primari
cours
follow
first
booster
subsequ
revaccin
given
interv
year
longer
unless
special
condit
appli
adult
cat
unknown
vaccin
statu
receiv
singl
initi
mlv
core
vaccin
inject
follow
booster
vaccin
year
later
cat
respond
vaccin
mlv
core
vaccin
maintain
solid
immun
immunolog
memori
mani
year
absenc
repeat
vaccin
emphas
consider
given
gener
appli
kill
core
vaccin
option
vaccin
particularli
vaccin
contain
bacteri
antigen
thu
chlamydophila
bordetella
product
requir
annual
booster
limit
protect
afford
product
therefor
adult
cat
may
today
still
receiv
annual
vaccin
howev
compon
vaccin
may
differ
year
typic
core
vaccin
current
administ
triennial
chosen
product
given
annual
vgg
awar
countri
product
contain
core
combin
avail
vgg
would
encourag
manufactur
make
full
rang
vaccin
avail
wherev
possibl
least
make
core
combin
want
give
vaccin
adult
cat
receiv
complet
cours
vaccin
fpv
fcv
kitten
includ
month
booster
may
regularli
vaccin
adult
requir
singl
dose
vaccin
boost
immun
note
mani
current
data
sheet
advis
circumst
cat
requir
two
vaccin
kitten
practic
unjustifi
simpli
contrari
fundament
principl
immunolog
memori
contrast
approach
may
justifi
adult
cat
vaccin
histori
unknown
serolog
test
anim
perform
past
year
becom
evid
one
trigger
felin
inject
site
sarcoma
fiss
may
administr
adjuv
felv
rabi
vaccin
subcutan
inject
includ
vaccin
tradit
given
interscapular
region
cat
common
site
format
fiss
infiltr
natur
tumour
meant
often
radic
surgic
resect
necessari
attempt
remov
lesion
north
america
respons
issu
recommend
protocol
wherebi
two
perceiv
adjuv
vaccin
would
administ
distinct
anatom
site
would
amen
surgic
remov
fiss
might
develop
accordingli
recommend
left
leg
leukaemia
right
leg
rabi
suggest
felv
vaccin
given
far
distal
possibl
left
hind
limb
whilst
rabi
vaccin
given
far
distal
possibl
right
hind
limb
recent
studi
evalu
effect
practic
compar
anatom
distribut
fiss
cat
recommend
made
practic
adopt
data
show
signific
decreas
preval
interscapular
fiss
increas
preval
tumour
right
left
hind
limb
notabl
also
increas
number
tumour
report
aris
right
left
later
abdomen
attribut
difficultli
inject
distal
hindlimb
abdomin
site
accident
inject
shaw
et
al
practic
adopt
outsid
north
america
given
recent
data
vgg
recommend
follow
approach
reduc
risk
fiss
vaccin
administ
cat
wherev
particularli
adjuv
product
administ
interscapular
particularli
adjuv
product
administ
subcutan
intramuscular
site
access
site
accept
safeti
vaccin
ie
avoid
accident
difficult
restraint
anim
would
appear
skin
later
thorax
abdomen
skin
later
abdomen
repres
best
choic
fiss
might
aris
site
may
readili
excis
occur
interscapular
intercost
region
extens
surgic
resect
administ
differ
site
occas
site
record
patient
record
vaccin
card
use
diagram
indic
product
administ
one
occas
site
rotat
occas
altern
practic
might
develop
group
polici
felin
vaccin
administ
specif
site
one
calendar
year
site
rotat
follow
vgg
encourag
case
suspect
fiss
notifi
via
appropri
nation
report
rout
suspect
advers
reaction
point
time
limit
avail
serolog
test
vaccin
antibodi
respons
cat
test
detect
fpv
antibodi
context
still
develop
titr
check
test
routin
use
usa
cpv
antibodi
use
detect
fpv
antibodi
cat
anticip
titr
test
serum
antibodi
fcv
ever
valu
measur
vaccin
immun
cat
therefor
vgg
endors
use
serolog
test
fpv
antibodi
test
result
use
way
describ
dog
emphas
antibodi
test
fiv
use
diagnos
diseas
valu
determin
immun
fiv
anim
shelter
hold
facil
anim
usual
await
adopt
rescu
reclaim
owner
gener
anim
shelter
character
random
sourc
popul
mostli
unknown
vaccin
histori
high
popul
turnov
high
infecti
diseas
risk
term
shelter
encompass
situat
rang
sanctuari
possess
stabl
popul
facil
admit
hundr
anim
per
day
rescu
foster
home
care
multipl
individu
litter
given
time
vaccin
strategi
vari
individu
pet
strategi
vaccin
shelter
anim
likelihood
exposur
potenti
devast
consequ
infect
necessit
clearli
defin
shelter
vaccin
program
shelter
medicin
differ
individu
care
practic
environ
erad
infecti
diseas
attain
possibl
howev
minim
spread
infect
within
popul
maintain
health
yet
infect
individu
overal
purpos
place
healthi
pet
welcom
home
time
effort
dedic
control
infecti
diseas
one
mani
variabl
complex
shelter
medicin
husbandri
equat
recommend
provid
attempt
address
issu
pertain
vaccin
diseas
control
guidelin
recommend
vaccin
use
shelter
given
unambigu
document
vaccin
provid
anim
time
admiss
shelter
reason
revaccin
canin
core
vaccin
felin
core
vaccin
specif
fcv
fhv
may
valu
boost
immun
vgg
discrimin
shelter
board
kennelcatteri
later
facil
fulli
vaccin
anim
may
temporarili
board
rel
short
period
time
eg
owner
vacat
requir
entri
facil
individu
dog
cat
fulli
vaccin
core
product
given
accord
guidelin
present
herein
use
vaccin
respiratori
infect
also
appropri
circumst
vgg
awar
countri
vaccin
protocol
anim
enter
board
kennelcatteri
formul
local
author
may
contrari
current
guidelin
eg
insist
annual
revaccin
vgg
encourag
author
reconsid
recommend
light
current
scientif
think
past
veterinari
practic
benefit
annual
administr
vaccin
encourag
owner
bring
pet
yearli
vaccin
veterinarian
abl
recogn
treat
diseas
earlier
might
otherwis
case
addit
annual
visit
provid
opportun
inform
client
import
aspect
canin
felin
health
care
unfortun
mani
client
come
believ
vaccin
import
reason
annual
veterinari
visit
veterinarian
concern
reduct
vaccin
frequenc
caus
client
forgo
annual
visit
qualiti
care
diminish
therefor
essenti
veterinarian
stress
import
aspect
comprehens
individu
health
care
program
emphasi
place
detail
vaccin
interview
comprehens
physic
examin
veterinarian
individu
patient
care
import
dental
care
proper
nutrit
appropri
diagnost
test
control
parasit
zoonot
diseas
also
address
evalu
pet
behaviour
concern
discuss
well
necess
frequent
examin
young
geriatr
anim
yearli
health
carevaccin
interview
assess
need
vaccin
pet
practition
explain
client
type
vaccin
avail
potenti
benefit
risk
applic
particular
anim
given
lifestyl
risk
exposur
whilst
anim
might
receiv
core
vaccin
everi
year
vaccin
requir
annual
administr
owner
continu
see
anim
vaccin
annual
region
incid
risk
factor
variou
infecti
diseas
also
discuss
way
reduc
impact
acquir
diseas
eg
avoid
overcrowd
improv
nutrit
restrict
access
infect
anim
also
review
vaccin
consid
one
compon
comprehens
prevent
health
care
plan
individu
base
age
breed
health
statu
environ
potenti
exposur
harm
agent
lifestyl
contact
anim
travel
habit
pet
age
signific
effect
prevent
health
care
need
given
individu
puppykitten
program
tradit
focus
vaccin
parasit
control
neuter
today
opportun
exist
incorpor
behaviour
counsel
zoonot
diseas
manag
age
pet
senior
care
program
becom
increasingli
popular
nutrit
dental
diseas
parasit
control
assess
counsel
take
place
individu
basi
throughout
life
pet
evid
older
dog
cat
fulli
vaccin
pup
kitten
requir
special
programm
core
vaccin
experiment
evid
show
age
dog
cat
persist
immunolog
memori
core
vaccin
readili
boost
administr
singl
vaccin
dose
contrast
age
anim
may
effici
mount
primari
immun
respons
novel
antigen
previous
encount
studi
uk
dog
cat
vaccin
first
time
rabi
pet
travel
clearli
shown
age
anim
fail
achiev
legal
requir
antibodi
titr
certain
breed
predispos
variou
diseas
earli
detect
particularli
neoplasia
manag
diseas
significantli
improv
qualiti
anim
entir
life
pet
chronic
medic
condit
warrant
period
schedul
medic
progress
examin
test
anim
receiv
certain
medic
also
warrant
therapeut
monitor
blood
level
andor
organ
system
develop
recheck
protocol
chronic
diseas
medic
includ
remind
system
greatli
improv
client
complianc
accordingli
pet
care
environ
pet
resid
profoundli
affect
health
statu
assess
annual
health
care
visit
order
defin
risk
factor
develop
appropri
prevent
measur
determin
extent
dog
cat
come
contact
anim
unobserv
circumst
veterinarian
assess
need
vaccin
dog
visit
kennel
groom
salon
common
area
wood
area
potenti
greater
risk
certain
infecti
diseas
dog
frequent
area
human
popul
becom
mobil
pet
popul
result
potenti
exposur
infecti
agent
parasit
environment
hazard
found
home
environ
determin
past
anticip
futur
travel
visit
allow
greater
individu
prevent
care
diagnost
test
plan
time
vaccin
administr
follow
inform
record
patient
perman
medic
record
vaccin
administr
name
initi
code
person
administ
vaccin
name
lot
serial
number
expiri
date
rout
vaccin
administr
use
vaccin
label
stamp
imprint
medic
record
outlin
pet
facilit
type
record
keep
mandatori
countri
advers
event
record
manner
alert
staff
member
futur
visit
inform
consent
document
medic
record
order
demonstr
relev
inform
provid
client
client
author
procedur
eg
use
product
discuss
least
notat
indic
discuss
risk
benefit
took
place
prior
vaccin
advers
event
defin
side
effect
unintend
consequ
includ
lack
protect
associ
administr
vaccin
product
includ
injuri
toxic
hypersensit
reaction
associ
vaccin
whether
event
directli
attribut
vaccin
advers
event
report
whether
associ
vaccin
recogn
suspect
vaccin
advers
event
report
identifi
product
anim
involv
event
individu
submit
report
report
field
observ
unexpect
vaccin
perform
import
mean
manufactur
regulatori
agenc
alert
potenti
vaccin
safeti
efficaci
problem
may
warrant
investig
purpos
safeti
studi
detect
rel
common
advers
event
rare
advers
event
detect
post
market
surveil
analysi
report
advers
event
advers
event
report
manufactur
andor
local
regulatori
author
mani
countri
government
surveil
scheme
avail
reaction
therefor
notifi
manufactur
vgg
recogn
gross
advers
event
imped
knowledg
ongo
safeti
product
vgg
would
activ
encourag
veterinarian
particip
surveil
scheme
particular
advers
event
well
document
report
serv
provid
baselin
futur
report
compar
addit
report
advers
event
lead
detect
previous
unrecogn
reaction
detect
increas
known
reaction
recognit
risk
factor
associ
reaction
identif
vaccin
lot
unusu
event
higher
number
advers
event
stimul
clinic
epidemiolog
laboratori
studi
therefor
veterinarian
encourag
report
clinic
signific
advers
event
occur
administr
licens
vaccin
report
vaccin
advers
event
indict
particular
vaccin
facilit
review
tempor
associ
condit
add
safeti
databas
product
work
vaccin
guidelin
group
gener
sponsor
plough
wsava
vgg
independ
group
academ
expert
formul
guidelin
without
consult
industri
